BDBM676702 2-[(11S,15R)-13,16-dioxa-2,4,10-triazatetracyclo[7.7.0.0{}[3,7].0{}[11,15]]hexadeca-1(9),2,5,7-tetraen-10-yl]-4-[2-[(2S)-2-(2-isopropylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-N-[3-nitro-4-[(oxan-4-ylmethyl)amino]benzenesulfonyl]benzamide::US20240166646, Example 2

SMILES CC(C)c1ccccc1[C@@H]1CCCN1C1CC2(CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(N4c5cc6cc[nH]c6nc5O[C@H]5COC[C@@H]54)c3)CC2)C1

InChI Key InChIKey=BSALPNJSCXQLNV-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 676702   

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 676702BDBM676702(2-[(11S,15R)-13,16-dioxa-2,4,10-triazatetracyclo[7...)
Affinity DataIC50: 0.220nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
US Patent